The incidence of inherited porphyrias in Europe - PubMed (original) (raw)
The incidence of inherited porphyrias in Europe
George Elder et al. J Inherit Metab Dis. 2013 Sep.
Abstract
Retrospective estimates of the prevalence of porphyrias have been reported but there has been no large scale prospective study of their incidence. The European Porphyria Network collected information prospectively over a 3 year period about the number of newly diagnosed symptomatic patients with an inherited porphyria (335 patients from 11 countries). Prevalence was calculated from the incidence and mean disease duration. The incidence of hepato-cellular carcinoma (HCC) in acute hepatic porphyria and the prevalence of patients with recurrent acute attacks of porphyria were also investigated. The incidence of symptomatic acute intermittent porphyria (AIP) was similar in all countries (0.13 per million per year; 95 % CI: 0.10 - 0.14) except Sweden (0.51; 95 % CI: 0.28-0.86). The incidence ratio for symptomatic AIP: variegate porphyria: hereditary coproporphyria was 1.00:0.62: 0.15. The prevalence of AIP (5.4 per million; 95 % CI: 4.5-6.3) was about half that previously reported. The prevalence of erythropoietic protoporphyria (EPP) was less uniform between countries and, in some countries, exceeded previous estimates. Fourteen new cases of HCC (11 from Sweden) were reported in patients with acute porphyria. Sixty seven patients (3 VP; 64 AIP: 53 females, 11 males) with recurrent attacks of acute porphyria were identified. The estimated percentage of patients with AIP that will develop recurrent acute attacks was 3-5 %. In conclusion, the prevalence of symptomatic acute porphyria may be decreasing, possibly due to improved management, whereas the prevalence of EPP may be increasing due to improved diagnosis and its greater recognition as a cause of photosensitivity.
Similar articles
- Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
Lissing M, Vassiliou D, Floderus Y, Harper P, Bottai M, Kotopouli M, Hagström H, Sardh E, Wahlin S. Lissing M, et al. J Intern Med. 2022 Jun;291(6):824-836. doi: 10.1111/joim.13463. Epub 2022 Mar 2. J Intern Med. 2022. PMID: 35112415 Free PMC article. - Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.
Yasuda M, Desnick RJ. Yasuda M, et al. Mol Genet Metab. 2019 Nov;128(3):332-341. doi: 10.1016/j.ymgme.2019.01.007. Epub 2019 Jan 18. Mol Genet Metab. 2019. PMID: 30737139 Free PMC article. Review. - Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.
Bonkovsky HL, Maddukuri VC, Yazici C, Anderson KE, Bissell DM, Bloomer JR, Phillips JD, Naik H, Peter I, Baillargeon G, Bossi K, Gandolfo L, Light C, Bishop D, Desnick RJ. Bonkovsky HL, et al. Am J Med. 2014 Dec;127(12):1233-41. doi: 10.1016/j.amjmed.2014.06.036. Epub 2014 Jul 10. Am J Med. 2014. PMID: 25016127 Free PMC article. - Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.
Yasuda M, Chen B, Desnick RJ. Yasuda M, et al. Mol Genet Metab. 2019 Nov;128(3):320-331. doi: 10.1016/j.ymgme.2018.11.012. Epub 2018 Nov 30. Mol Genet Metab. 2019. PMID: 30594473 Free PMC article. Review. - Porphyrias in Japan: compilation of all cases reported through 2002.
Kondo M, Yano Y, Shirataka M, Urata G, Sassa S. Kondo M, et al. Int J Hematol. 2004 Jun;79(5):448-56. doi: 10.1532/ijh97.03127. Int J Hematol. 2004. PMID: 15239394 Review.
Cited by
- Hepatocellular Carcinoma in Acute Hepatic Porphyria: A Meta-Analysis of Observational Studies.
Singal AK, Reddy RK, Gudiwada MC, Jasti JJ, Anderson KE. Singal AK, et al. Dig Dis Sci. 2024 Nov;69(11):4268-4274. doi: 10.1007/s10620-024-08661-w. Epub 2024 Oct 22. Dig Dis Sci. 2024. PMID: 39438413 - Estimating carrier rates and prevalence of porphyria-associated gene variants in the Chinese population based on genetic databases.
Wang Y, Li N, Zhang S. Wang Y, et al. Orphanet J Rare Dis. 2024 Sep 12;19(1):337. doi: 10.1186/s13023-024-03287-7. Orphanet J Rare Dis. 2024. PMID: 39267094 Free PMC article. - Drug-associated porphyria: a pharmacovigilance study.
Wang Q, Zhuang JL, Han B, Chen M, Zhao B. Wang Q, et al. Orphanet J Rare Dis. 2024 Aug 1;19(1):286. doi: 10.1186/s13023-024-03294-8. Orphanet J Rare Dis. 2024. PMID: 39090656 Free PMC article. - Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.
Balogun O, Nejak-Bowen K. Balogun O, et al. Semin Liver Dis. 2024 May;44(2):209-225. doi: 10.1055/s-0044-1787076. Epub 2024 May 17. Semin Liver Dis. 2024. PMID: 38772406 Free PMC article. Review. - Unveiling the Chameleon: A Case Report on Acute Intermittent Porphyria.
Shrestha M, Amin S, Reggio C, Pokhrel A, Munankami S, Nypaver J, Gupta R, Donato A. Shrestha M, et al. Cureus. 2024 Mar 15;16(3):e56222. doi: 10.7759/cureus.56222. eCollection 2024 Mar. Cureus. 2024. PMID: 38618379 Free PMC article.
References
- J Intern Med. 2011 Mar;269(3):278-88 - PubMed
- Medicine (Baltimore). 2005 Jan;84(1):48-60 - PubMed
- Acta Med Scand. 1984;215(3):271-4 - PubMed
- J Hum Genet. 2003;48(2):70-6 - PubMed
- J Med Genet. 1979 Apr;16(2):134-9 - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous